Inovio Pharmaceuticals, Inc. Stock Performance
as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
$2.35$2.44
0.42%
Downside
3.39%
Upside
52 Week's Low
52 Week's High
$1.3$5.8344.92%
Downside
147.03%
Upside
Inovio Pharmaceuticals, Inc. share price movements today
- Previous Close
- $2.46
- Open
- $2.41
- Volume
- 823.5K
- Day's Low - High
- $2.35 - $2.44
- 52 Week Low - High
- $1.3 - $5.83
Inovio Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- + 1.73 %
- 3 Month Return
- + 69.06 %
- 1 Year Return
- -58.11 %
- 3 Year Return
- -89.12 %
- 5 Year Return
- -98.35 %
Inovio Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Inovio Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$130.7M
EPS (TTM)
-2.054
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.56
Industry PE ratio
-2.4711878453038674
PEG Ratio
0EBITDA
-94.3M
Revenue (TTM)
182.3K
Profit Margin
0.00%
Return On Equity TTM
14821300.00%
Inovio Pharmaceuticals, Inc. Stock Valuation
Track how Inovio Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Inovio Pharmaceuticals, Inc. in the last 5 years
Lowest (-139.20x)
June 30, 2021
Industry (-2.47x)
October 18, 2025
Today (-1.56x)
October 18, 2025
Highest (-0.63x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.56x
Inovio Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Inovio Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $130.7M | -98.35% | -1.56 | 0.00% | |
| BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
| NA | $36.7B | NA | NA | -3.89% | |
| BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
| BUY | $60.3B | -3.62% | 14.35 | 31.37% |
Stock Returns calculator for Inovio Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Inovio Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Inovio Pharmaceuticals, Inc. investment value today
Current value as on today
₹46,862
Returns
Returns from Inovio Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,794 (+4.79%)
Analyst Recommendation on Inovio Pharmaceuticals, Inc. Stock
Based on 9 analysts
55.56%
Buy
44.44%
Hold
0.00%
Sell
Based on 9 analysts, 55.56% of analysts recommend a 'BUY' rating for Inovio Pharmaceuticals, Inc.. Average target price of $7.47
Inovio Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Inovio Pharmaceuticals, Inc..
What analysts predicted
68.41%UPSIDE
Target Price
$7.47
Current Price
$2.36
Analyzed by
9 Analysts
Target
$7.47
Inovio Pharmaceuticals, Inc. target price $7.47, a slight upside of 68.41% compared to current price of $2.36. According to 9 analysts rating.
Inovio Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest
Search interest for Inovio Pharmaceuticals, Inc. Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Inovio Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Inovio Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Inovio Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Inovio Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Inovio Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 120.9%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 237.3%
NEGATIVE IMPACTPrice Dip
In the last 7 days, INO stock has moved down by -8.6%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -19.38M → -23.51M (in $), with an average decrease of 10.5% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 116.99K → 65.34K (in $), with an average decrease of 44.2% per quarter
About Inovio Pharmaceuticals, Inc.
| Organisation | Inovio Pharmaceuticals, Inc. |
| Headquarters | 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
| Industry | Health Technology |
| CEO | Dr. Jacqueline E. Shea Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Inovio Pharmaceuticals, Inc.
Name | Title |
|---|---|
Thomas Hong | Manager of Investor Relations |
Mr. E. J. Brandreth MBA | Senior Vice President of Quality Assurance |
Dr. Jeffrey Skolnik | Senior Vice President of Clinical Development |
Mr. Robert J. Juba Jr. | Senior Vice President of Biological Manufacturing & Clinical Supply Management |
Dr. Jacqueline E. Shea Ph.D. | CEO, President & Director |
Mr. Peter D. Kies | Chief Financial Officer |
Dr. Michael Sumner M.D. | Chief Medical Officer |
Dr. Laurent M. Humeau Ph.D. | Chief Scientific Officer & Chairman of the Scientific Advisory Board |
Mr. Robert L. Crotty J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
Mr. Shawn D. Bridy M.A., M.B.A. | Senior Vice President of Business Development |
FAQs
What is Inovio Pharmaceuticals, Inc. share price today?
Inovio Pharmaceuticals, Inc. share price today is $2.36 as on at the close of the market. Inovio Pharmaceuticals, Inc. share today touched a day high of $2.44 and a low of $2.35.
What is the 52 week high and 52 week low for Inovio Pharmaceuticals, Inc. share?
Inovio Pharmaceuticals, Inc. share touched a 52 week high of $5.83 on and a 52 week low of $1.3 on . Inovio Pharmaceuticals, Inc. stock price today i.e. is closed at $2.36,which is 59.52% down from its 52 week high and 81.54% up from its 52 week low.
What is Inovio Pharmaceuticals, Inc.'s market capitalisation today?
Inovio Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
How to invest in Inovio Pharmaceuticals, Inc. Stock (INO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Inovio Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inovio Pharmaceuticals, Inc. Shares that will get you 0.6356 shares as per Inovio Pharmaceuticals, Inc. share price of $2.36 per share as on October 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Inovio Pharmaceuticals, Inc. Stock (INO) from India?
Indian investors can start investing in Inovio Pharmaceuticals, Inc. (INO) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Inovio Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Inovio Pharmaceuticals, Inc. share’s latest price of $2.36 as on October 18, 2025 at 1:29 am IST, you will get 4.2373 shares of Inovio Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Inovio Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Inovio Pharmaceuticals, Inc. stock has given -98.35% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?